Introduction to Anatomy and Physiology and Drug Disposition for Nonhumans
This webinar was originally presented on Thursday, October 10, 2024.
Overview — What is going to happen to that drug that is approved for use in humans when you give it to a dog, or a cat, or even an elephant? Pharmacy curricula do not typically include exposure to the principles of drug disposition in non-humans, so most pharmacy professionals are at a loss when a human-labeled drug does not do what it is expected in a pet. This presentation will explore comparative differences in anatomy and physiology of companion animals versus humans and how those differences impact successful pharmacotherapeutic outcomes.
Speaker — Gigi Davidson, BSPharm, DICVP, FACVP, FSVHP, is the former Director of Clinical Pharmacy at the NC State University College of Veterinary Medicine where she practiced veterinary pharmacy for 35 years. Ms. Davidson received a pharmacy degree from UNC Chapel Hill in 1983 and earned Diplomate status in the International College of Veterinary Pharmacy in 2001. (read full bio)
Gigi Davidson is the former Director of Clinical Pharmacy at the NC State University College of Veterinary Medicine where she practiced veterinary pharmacy for 35 years. Ms. Davidson received a pharmacy degree from UNC Chapel Hill in 1983 and earned Diplomate status in the International College of Veterinary Pharmacy in 2001. She was inducted into the Phi Zeta Honor Society in 2006 as an honorary member for distinguished advancement of veterinary science. Gigi is a past President of the Society of Veterinary Hospital Pharmacists and of the American College of Veterinary Pharmacists. Ms. Davidson is the ACVP delegate to the American Pharmacists Association House of Delegates. Ms. Davidson was the Chair of the United States Pharmacopeia Compounding Expert Committee from 2010-2020 and continues to serve as a member. Gigi is the recipient of USP’s Beal Award when in 2015 she became the first female and first veterinary recipient of that award. She has many publications in peer-reviewed scientific journals, and her primary area of research interest is stability, safety, and efficacy of compounded therapies in non-human species. Her research interests in retirement include drug disposition in honey bees and pharmacological action of plant pollens and nectars on honey bee colonies.
